| Biomarker ID | 1490 |
| PMID | 25075566 |
| Year | 2014 |
| Biomarker | Interferon β (IFNβ) |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Decreased in patients with Biochemical Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include: Toll-like Receptor Signaling Pathway; RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways; Immune response IFN alpha/beta signaling pathway; Measles; Human cytomegalovirus infection |
| Experiment | Recurrence Vs No Recurrence |
| Type of Biomarker | Prognostic |
| Cohort | 118 patients with primary prostate cancer (78 without and 40 with recurrence during the follow-up period) were selected |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.008 |
| Method Used | Immunohistochemistry |
| Clinical | No |
| Remarks | cutoff point: 170 |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |